Field Access Manager – Plasma-Derived Therapies
Company | Takeda |
---|---|
Location | Minnesota, USA, Wisconsin, USA, Illinois, USA |
Salary | $145600 – $200200 |
Type | Full-Time |
Degrees | Bachelor’s, MBA |
Experience Level | Senior |
Requirements
- Bachelor’s Degree.
- 5+ years of field-based experience in account management, sales or medical affairs.
- Strong knowledge of the reimbursement landscape and the practice management environment.
- Demonstrated ability to develop and execute account-based strategies to drive access outcomes.
- Excellent written and verbal communication skills.
- Expertise in account management, relationship development, and issue resolution.
- Outstanding interpersonal skills and flexibility to meet evolving customer and organizational needs.
Responsibilities
- Serve as a key resource to navigate reimbursement and access challenges for patients and providers, ensuring timely and effective access to Takeda’s therapies.
- Deliver tailored, field-based education on reimbursement processes to key accounts, including provider group practices, hospitals, academic institutions, specialty pharmacies, and other healthcare stakeholders.
- Build and maintain collaborative relationships with healthcare organizations, identifying and resolving reimbursement and access issues to ensure seamless therapy initiation and continuation.
- Provide education and support to internal teams, equipping colleagues with the knowledge and tools to address complex reimbursement and access scenarios effectively.
- Stay informed on healthcare policies, reimbursement trends, and regulatory requirements to proactively address challenges and opportunities in the marketplace.
Preferred Qualifications
- Minimum of 5 years of relevant experience in reimbursement roles within the pharmaceutical, biotech, or rare disease industry.
- MBA or advanced degree.
- Experience in healthcare policy, reimbursement, market access, or related fields.
- Familiarity with buy-and-bill and pharmacy models.
- Experience with specialty or high-cost therapies in chronic or acute care settings.